Evaluation of the maternal and neonatal effects of the oxytocin antagonist, atosiban, in a cross-fostering study in rats

Melin, 1993, Oxytocin antagonists in preterm labour and delivery, Baillière’s Clin Obstet Gynaecol, 7, 577, 10.1016/S0950-3552(05)80449-3 Goodwin, 1994, The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human, Am J Obstet Gynecol, 170, 474, 10.1016/S0002-9378(94)70214-4 Thornton, 2001, Oxytocin antagonists: clinical and scientific considerations, Exp Physiol, 86, 297, 10.1113/eph8602186 Romero, 2000, An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue, Am J Obstet Gynecol, 182, 1173, 10.1067/mob.2000.95834 Christian MS, Hoberman AM, Foss JA. Perinatal and postnatal reproduction study of RWJ-22164-021 administered subcutaneously to Crl:CD®BR, VAF/Plus® rats (Segment III evaluation). Includes postnatal “behavioral/functional” evaluation. Horsham, PA: Argus Research Laboratories Inc.; 1995. Kumaresen, 1971, Oxytocin antibody and lactation and parturition in rats, Nat Lond, 230, 468, 10.1038/230468a0 Glasier, 1990, Physiology of lactation, Baillière’s Clin Endocr Metab, 4, 379, 10.1016/S0950-351X(05)80056-4 Lincoln, 1982, Neuroendocrine control of milk ejection, J Reprod Fertil, 65, 571, 10.1530/jrf.0.0650571 Bruckmaier, 1997, Inhibition of milk ejection in cows by oxytocin receptor blockade, α-adrenergic receptor stimulation and in unfamiliar surroundings, J Dairy Res, 64, 315, 10.1017/S002202999700232X Wellnitz, 1999, Atosiban, an oxytocin receptor blocking agent: pharmacokinetics and inhibition of milk ejection in dairy cows, J Dairy Res, 66, 1, 10.1017/S0022029998003227 Knight, 1994, Use of an oxytocin analogue to determine cisternal and alveolar milk pool sizes in goats, J Dairy Res, 77, 84 Magnusson, 1985, The effect of 1-deamino-2-Tyr(ethyl) oxytocin upon peri- and postnatal development of the rat: growth retardation of the offspring, Arch Toxicol, 57, 246, 10.1007/BF00324786 Young, 1996, Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition, J Neuroendocr, 8, 847, 10.1046/j.1365-2826.1996.05266.x Pedersen, 1979, Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin, Proc Natl Acad Sci U.S.A., 76, 6661, 10.1073/pnas.76.12.6661 Insel, 1992, Oxytocin: a neuropeptide for affiliation: evidence from behavioral, receptor autoradiographic, and comparative studies, Psychoneuroendocrinology, 17, 3, 10.1016/0306-4530(92)90073-G van Leengoed, 1987, Inhibition of post-partum maternal behaviour in the rat by injecting an oxytocin antagonist into the cerebral ventricles, J Endocr, 112, 275, 10.1677/joe.0.1120275 Schmidt, 1990, Oxytocin receptors in rat kidney during development, Am J Physiol, 259, F872 Dunnett, 1955, A multiple comparison procedure for comparing several treatments with a control, J Am Stat Assoc, 50, 1096, 10.2307/2281208 Kruskal, 1952, Use of ranks in one-criterion variance analysis, J Am Stat Assoc, 47, 583, 10.2307/2280779 Conover WJ. Practical nonparametric statistics. 2nd ed. New York: Wiley; 1980. Streeter AJ, Zane CS, Stubbs RJ, Takacs AR. Evaluation of the bioavailability and pharmacokinetics of atosiban in female Crl:CD®B.R., VAF/PLUS® rats following administration of a single subcutaneous and intravenous infusion dose of 20mg/kg. Internal report no. 418469:1-DM-95066. Raritan, NJ: RW Johnson Pharmaceutical Research Institute; 1996. Christopher RJ, Stubbs RJ, Takacs AR. Determination of the maternal and fetal exposure of atosiban after subcutaneous administration to Sprague–Dawley rats on gestation days 15 through 20 (Segment III Peri- and Postnatal Reproduction Study). Internal report no. 404850:1-DM-94025. Raritan, NJ: RW Johnson Pharmaceutical Research Institute; 1996. Zellers JE, Davis CC, Oldham JW, Mackey MJ, Szot RJ. Subcutaneous developmental toxicity study of RWJ-22164-021 (atosiban) in female Crl:CD®B.R., VAF/Plus® rats. Internal report no. 382520:1-DS-94307. Raritan, NJ: RW Johnson Pharmaceutical Research Institute; 1996. Zellers JE, Krayer JH, Takacs AR, Mackey MJ, Oldham JW. Subcutaneous developmental toxicity study of RWJ-22164-021 (atosiban) in female New Zealand White rabbits. Internal report no. 404286:1-DS-94314. Raritan, NJ: RW Johnson Pharmaceutical Research Institute; 1996. Wakerley JB, Clarke G, Summerlee AJS. Milk ejection and its control. In: Knobil E, Neill J, editors. The physiology of reproduction, vol. 2. New York: Raven; 1988, p. 2283–323. Crowley, 1992, Neurochemical regulation of oxytocin secretion in lactation, Endocr Revs, 13, 33